Seattle, WA · Founded 2023 · Privately Held (backing)
Developer of a biotechnology platform designed to engineer de novo biologics for the treatment of complex diseases. Accipiter Biosciences is based in Seattle, WA and was founded in 2023. It was valued at $22 million at its seed round in Nov 2025, the last priced event on record. It has raised $13.6 million across 2 recorded rounds; the latest was a $13.6 million early-stage round in May 2024.
PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$13.6M
Last round
Early Stage VC
May 2024
Cap table — not yet on record
Accipiter Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Accipiter Biosciences with a free account
·Watch Accipiter Biosciences: the Monday email on marks, rounds and moves
Where does Accipiter Biosciences's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Accipiter Biosciences's 2 recorded funding rounds.
